Method for treating a neurodegenerative disease by administering an anti-cellular prion protein (PrP
Abstract:
The present disclosure provides antibodies and antigen-binding fragments capable of binding PrPC. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.
Public/Granted literature
Information query
Patent Agency Ranking
0/0